|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2004-4-21
|
|
pubmed:abstractText |
Elevated NO production has been detected in patients suffering from various arthropathies; however, its role and regulation during gouty arthritis remain largely unexplored. Monosodium urate (MSU) crystals, the causative agent of gout, have been shown to induce NO generation in vivo and inducible NO synthase (iNOS) expression in human monocytes. The present study was designed to evaluate the ability of MSU crystals to modulate macrophage (M phi) iNOS expression and NO synthesis and to investigate the molecular mechanisms underlying these cellular responses. We found that MSU crystals did not induce NO production in murine J774 M phi. However, a synergistic effect on the level of iNOS expression and NO generation was observed in cells exposed to MSU crystals in combination with IFN-gamma. Characterization of the second messengers involved revealed the requirement of IFN-gamma-mediated Janus kinase 2/STAT1 alpha activation even though MSU crystals did not modulate this signaling cascade by themselves. MSU crystals exerted their up-regulating effect by increasing extracellular signal-regulated kinase (ERK) 1/2 phosphorylation and NF-kappa B nuclear translocation in response to IFN-gamma. The use of specific inhibitors against either NF-kappa B or the ERK1/2 pathway significantly reduced MSU + IFN-gamma-inducible NF-kappa B activity, iNOS expression, and NO production. Altogether, these data indicate that MSU crystals exert a potent synergistic effect on the IFN-gamma-inducible M phi NO generation via ERK1/2- and NF-kappa B-dependent pathways. Understanding the molecular mechanisms through which MSU crystals amplify M phi responses to proinflammatory cytokines such as IFN-gamma will contribute to better define their role in NO regulation during gout, in particular, and inflammation, in general.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-gamma,
http://linkedlifedata.com/resource/pubmed/chemical/JAK2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Jak2 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Janus Kinase 2,
http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinase 1,
http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinase 3,
http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/NF-kappa B,
http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide,
http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide Synthase,
http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide Synthase Type II,
http://linkedlifedata.com/resource/pubmed/chemical/Nos2 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Protein-Tyrosine Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/STAT1 Transcription Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Stat1 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Trans-Activators,
http://linkedlifedata.com/resource/pubmed/chemical/Uric Acid
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0022-1767
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
172
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
5734-42
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:15100320-Active Transport, Cell Nucleus,
pubmed-meshheading:15100320-Animals,
pubmed-meshheading:15100320-Cell Line,
pubmed-meshheading:15100320-Cell Nucleus,
pubmed-meshheading:15100320-Crystallization,
pubmed-meshheading:15100320-DNA-Binding Proteins,
pubmed-meshheading:15100320-Drug Synergism,
pubmed-meshheading:15100320-Interferon-gamma,
pubmed-meshheading:15100320-Janus Kinase 2,
pubmed-meshheading:15100320-MAP Kinase Signaling System,
pubmed-meshheading:15100320-Macrophages,
pubmed-meshheading:15100320-Mice,
pubmed-meshheading:15100320-Mitogen-Activated Protein Kinase 1,
pubmed-meshheading:15100320-Mitogen-Activated Protein Kinase 3,
pubmed-meshheading:15100320-Mitogen-Activated Protein Kinases,
pubmed-meshheading:15100320-NF-kappa B,
pubmed-meshheading:15100320-Nitric Oxide,
pubmed-meshheading:15100320-Nitric Oxide Synthase,
pubmed-meshheading:15100320-Nitric Oxide Synthase Type II,
pubmed-meshheading:15100320-Protein-Tyrosine Kinases,
pubmed-meshheading:15100320-Proto-Oncogene Proteins,
pubmed-meshheading:15100320-RNA, Messenger,
pubmed-meshheading:15100320-STAT1 Transcription Factor,
pubmed-meshheading:15100320-Trans-Activators,
pubmed-meshheading:15100320-Up-Regulation,
pubmed-meshheading:15100320-Uric Acid
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Monosodium urate crystals synergize with IFN-gamma to generate macrophage nitric oxide: involvement of extracellular signal-regulated kinase 1/2 and NF-kappa B.
|
|
pubmed:affiliation |
Centre de Recherche en Infectiologie, Centre Hospitalier Universitaire de Québec, Pavillon Centre Hospitalier de l'Université Laval, and Département de Biologie Médicale Faculté de Médecine, Université Laval, Ste-Foy, Quebec, Canada.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
